Switch to:
Also traded in: Denmark, Germany, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.13
WILYY's Cash-to-Debt is ranked lower than
91% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. WILYY: 0.13 )
Ranked among companies with meaningful Cash-to-Debt only.
WILYY' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.06  Med: 0.13 Max: No Debt
Current: 0.13
Equity-to-Asset 0.45
WILYY's Equity-to-Asset is ranked lower than
72% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. WILYY: 0.45 )
Ranked among companies with meaningful Equity-to-Asset only.
WILYY' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.31  Med: 0.45 Max: 0.5
Current: 0.45
0.31
0.5
Interest Coverage 45.95
WILYY's Interest Coverage is ranked lower than
56% of the 221 Companies
in the Global Medical Devices industry.

( Industry Median: 97.42 vs. WILYY: 45.95 )
Ranked among companies with meaningful Interest Coverage only.
WILYY' s Interest Coverage Range Over the Past 10 Years
Min: 6.18  Med: 16.78 Max: N/A
Current: 45.95
Piotroski F-Score: 7
Altman Z-Score: 4.01
Beneish M-Score: -2.44
WACC vs ROIC
4.56%
13.96%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 16.08
WILYY's Operating Margin % is ranked higher than
83% of the 299 Companies
in the Global Medical Devices industry.

( Industry Median: 2.42 vs. WILYY: 16.08 )
Ranked among companies with meaningful Operating Margin % only.
WILYY' s Operating Margin % Range Over the Past 10 Years
Min: 17.61  Med: 19.78 Max: 32.26
Current: 16.08
17.61
32.26
Net Margin % 12.24
WILYY's Net Margin % is ranked higher than
81% of the 299 Companies
in the Global Medical Devices industry.

( Industry Median: 1.92 vs. WILYY: 12.24 )
Ranked among companies with meaningful Net Margin % only.
WILYY' s Net Margin % Range Over the Past 10 Years
Min: 12.7  Med: 14.27 Max: 17.71
Current: 12.24
12.7
17.71
ROE % 21.76
WILYY's ROE % is ranked higher than
91% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 1.20 vs. WILYY: 21.76 )
Ranked among companies with meaningful ROE % only.
WILYY' s ROE % Range Over the Past 10 Years
Min: 23.76  Med: 47.24 Max: 164.41
Current: 21.76
23.76
164.41
ROA % 10.13
WILYY's ROA % is ranked higher than
84% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 0.07 vs. WILYY: 10.13 )
Ranked among companies with meaningful ROA % only.
WILYY' s ROA % Range Over the Past 10 Years
Min: 11.21  Med: 16.96 Max: 29.89
Current: 10.13
11.21
29.89
ROC (Joel Greenblatt) % 47.27
WILYY's ROC (Joel Greenblatt) % is ranked higher than
86% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 3.61 vs. WILYY: 47.27 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
WILYY' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 50.74  Med: 57.28 Max: 130.11
Current: 47.27
50.74
130.11
3-Year Revenue Growth Rate 9.60
WILYY's 3-Year Revenue Growth Rate is ranked higher than
71% of the 224 Companies
in the Global Medical Devices industry.

( Industry Median: 3.80 vs. WILYY: 9.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
WILYY' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 6.5  Med: 9.6 Max: 15.4
Current: 9.6
6.5
15.4
3-Year EBITDA Growth Rate 11.50
WILYY's 3-Year EBITDA Growth Rate is ranked higher than
59% of the 193 Companies
in the Global Medical Devices industry.

( Industry Median: 4.10 vs. WILYY: 11.50 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
WILYY' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -4.9  Med: 11.5 Max: 23.2
Current: 11.5
-4.9
23.2
3-Year EPS without NRI Growth Rate 9.60
WILYY's 3-Year EPS without NRI Growth Rate is ranked higher than
60% of the 190 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. WILYY: 9.60 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
WILYY' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -1.9  Med: 10.3 Max: 21.1
Current: 9.6
-1.9
21.1
GuruFocus has detected 4 Warning Signs with William Demant Holding A/S $WILYY.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» WILYY's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with WILYY

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 334510    SIC: 3845
Compare:OTCPK:CHEOY, NAS:ABMD, OTCPK:CNVVY, NAS:MASI, NAS:NUVA, OTCPK:FSPKF, OTCPK:EKTAF, NAS:IART, OTCPK:GGNDF, NYSE:VAR, NAS:WMGI, NYSE:NVRO, NYSE:GMED, NAS:ALGN, OTCPK:SONVY, NAS:LIVN, NYSE:TFX, OTCPK:NHNKY, NAS:CYNO, NAS:INGN » details
Traded in other countries:WDH.Denmark, WDH1.Germany, 0RGT.UK,
William Demant Holding A/S develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals.

William Demant Holding A/S is incorporated in Denmark. The Company is a hearing product and equipment manufacturer. The company operated in three segments namely Hearing Aids, Diagnostic Instruments, and Personal Communication. The Hearing Aid segment offers hearing aids under the Oticon and Bernafon brand names. Oticon offers several hearing aid lines, including EPOQ, Dual, Vigo, Hit, Sumo DM, and products for the elderly. Bernafon offers many hearing aid lines, including Verite, Icos, Brite, Move, Swissear, Symbio XT, Prio, Xtreme, Avanti, Neo, and Win. The products range from affordable to premium depending on the features needed. The Diagnostic Instruments segment includes Maico Diagnostics, Interacoustics, and Amplivox. Maico offers audiometers, middle ear analyzers, BERAphones, OAE test systems, software, and services. Interacoustics offer audiometers, middle ear analyzers, HA fitting, VNG balance systems, and rhiometry. Amplivox provides manual and automatic screening audiometers, audiogram software, diagnostic audiometers, acoustic booths, electro acoustic ear simulator, tympanometers, middle ear analyzers, spirometers, vision screeners, audiocups, and accessories and consumables. The Personal Communication segment operates under Phonic Ear and Sennheiser Communications. Phonic Ear offers sound field systems, teleloop and loudspeaker systems, infrared systems, and assistive listening devices.

Ratios

vs
industry
vs
history
PE Ratio 27.11
WILYY's PE Ratio is ranked higher than
51% of the 172 Companies
in the Global Medical Devices industry.

( Industry Median: 25.50 vs. WILYY: 27.11 )
Ranked among companies with meaningful PE Ratio only.
WILYY' s PE Ratio Range Over the Past 10 Years
Min: 12.03  Med: 24.7 Max: 40
Current: 27.11
12.03
40
Forward PE Ratio 21.46
WILYY's Forward PE Ratio is ranked higher than
66% of the 56 Companies
in the Global Medical Devices industry.

( Industry Median: 23.92 vs. WILYY: 21.46 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 27.11
WILYY's PE Ratio without NRI is ranked higher than
50% of the 168 Companies
in the Global Medical Devices industry.

( Industry Median: 25.48 vs. WILYY: 27.11 )
Ranked among companies with meaningful PE Ratio without NRI only.
WILYY' s PE Ratio without NRI Range Over the Past 10 Years
Min: 12.03  Med: 24.7 Max: 40
Current: 27.11
12.03
40
Price-to-Owner-Earnings 32.45
WILYY's Price-to-Owner-Earnings is ranked lower than
51% of the 103 Companies
in the Global Medical Devices industry.

( Industry Median: 30.29 vs. WILYY: 32.45 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
WILYY' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 12.75  Med: 30.65 Max: 71.82
Current: 32.45
12.75
71.82
PB Ratio 5.61
WILYY's PB Ratio is ranked lower than
72% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 3.17 vs. WILYY: 5.61 )
Ranked among companies with meaningful PB Ratio only.
WILYY' s PB Ratio Range Over the Past 10 Years
Min: 4.26  Med: 9.4 Max: 70.24
Current: 5.61
4.26
70.24
PS Ratio 3.58
WILYY's PS Ratio is ranked lower than
52% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 3.29 vs. WILYY: 3.58 )
Ranked among companies with meaningful PS Ratio only.
WILYY' s PS Ratio Range Over the Past 10 Years
Min: 1.91  Med: 3.44 Max: 7.11
Current: 3.58
1.91
7.11
Price-to-Free-Cash-Flow 33.21
WILYY's Price-to-Free-Cash-Flow is ranked lower than
58% of the 106 Companies
in the Global Medical Devices industry.

( Industry Median: 27.61 vs. WILYY: 33.21 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
WILYY' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 16.71  Med: 31.47 Max: 52.15
Current: 33.21
16.71
52.15
Price-to-Operating-Cash-Flow 24.01
WILYY's Price-to-Operating-Cash-Flow is ranked lower than
61% of the 135 Companies
in the Global Medical Devices industry.

( Industry Median: 18.12 vs. WILYY: 24.01 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
WILYY' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 12.43  Med: 22.42 Max: 38.21
Current: 24.01
12.43
38.21
EV-to-EBIT 22.98
WILYY's EV-to-EBIT is ranked lower than
52% of the 169 Companies
in the Global Medical Devices industry.

( Industry Median: 21.48 vs. WILYY: 22.98 )
Ranked among companies with meaningful EV-to-EBIT only.
WILYY' s EV-to-EBIT Range Over the Past 10 Years
Min: 9.9  Med: 19.1 Max: 28.7
Current: 22.98
9.9
28.7
EV-to-EBITDA 19.55
WILYY's EV-to-EBITDA is ranked lower than
57% of the 175 Companies
in the Global Medical Devices industry.

( Industry Median: 15.79 vs. WILYY: 19.55 )
Ranked among companies with meaningful EV-to-EBITDA only.
WILYY' s EV-to-EBITDA Range Over the Past 10 Years
Min: 9.9  Med: 18.2 Max: 25.5
Current: 19.55
9.9
25.5
PEG Ratio 2.74
WILYY's PEG Ratio is ranked lower than
57% of the 76 Companies
in the Global Medical Devices industry.

( Industry Median: 2.33 vs. WILYY: 2.74 )
Ranked among companies with meaningful PEG Ratio only.
WILYY' s PEG Ratio Range Over the Past 10 Years
Min: 0.74  Med: 2.47 Max: 12.98
Current: 2.74
0.74
12.98
Shiller PE Ratio 36.09
WILYY's Shiller PE Ratio is ranked higher than
65% of the 49 Companies
in the Global Medical Devices industry.

( Industry Median: 49.62 vs. WILYY: 36.09 )
Ranked among companies with meaningful Shiller PE Ratio only.
WILYY' s Shiller PE Ratio Range Over the Past 10 Years
Min: 23.92  Med: 30.82 Max: 36.74
Current: 36.09
23.92
36.74
Current Ratio 0.91
WILYY's Current Ratio is ranked lower than
89% of the 313 Companies
in the Global Medical Devices industry.

( Industry Median: 2.45 vs. WILYY: 0.91 )
Ranked among companies with meaningful Current Ratio only.
WILYY' s Current Ratio Range Over the Past 10 Years
Min: 0.78  Med: 0.85 Max: 1.82
Current: 0.91
0.78
1.82
Quick Ratio 0.68
WILYY's Quick Ratio is ranked lower than
88% of the 313 Companies
in the Global Medical Devices industry.

( Industry Median: 1.79 vs. WILYY: 0.68 )
Ranked among companies with meaningful Quick Ratio only.
WILYY' s Quick Ratio Range Over the Past 10 Years
Min: 0.52  Med: 0.58 Max: 1.06
Current: 0.68
0.52
1.06
Days Inventory 161.60
WILYY's Days Inventory is ranked lower than
62% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: 130.88 vs. WILYY: 161.60 )
Ranked among companies with meaningful Days Inventory only.
WILYY' s Days Inventory Range Over the Past 10 Years
Min: 157.55  Med: 166.88 Max: 243.7
Current: 161.6
157.55
243.7
Days Sales Outstanding 77.81
WILYY's Days Sales Outstanding is ranked lower than
59% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 66.78 vs. WILYY: 77.81 )
Ranked among companies with meaningful Days Sales Outstanding only.
WILYY' s Days Sales Outstanding Range Over the Past 10 Years
Min: 64.71  Med: 75.63 Max: 85.21
Current: 77.81
64.71
85.21
Days Payable 63.01
WILYY's Days Payable is ranked higher than
52% of the 254 Companies
in the Global Medical Devices industry.

( Industry Median: 58.05 vs. WILYY: 63.01 )
Ranked among companies with meaningful Days Payable only.
WILYY' s Days Payable Range Over the Past 10 Years
Min: 48.58  Med: 54.34 Max: 70.23
Current: 63.01
48.58
70.23

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio 2.90
WILYY's 3-Year Average Share Buyback Ratio is ranked higher than
95% of the 199 Companies
in the Global Medical Devices industry.

( Industry Median: -3.90 vs. WILYY: 2.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
WILYY' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: 0.4  Med: 1.8 Max: 4.5
Current: 2.9
0.4
4.5

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 93.58
WILYY's Price-to-Tangible-Book is ranked lower than
98% of the 283 Companies
in the Global Medical Devices industry.

( Industry Median: 4.24 vs. WILYY: 93.58 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
WILYY' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 14.38  Med: 23.7 Max: 159.8
Current: 93.58
14.38
159.8
Price-to-Intrinsic-Value-DCF (Earnings Based) 2.05
WILYY's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked higher than
55% of the 22 Companies
in the Global Medical Devices industry.

( Industry Median: 2.17 vs. WILYY: 2.05 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Graham-Number 10.61
WILYY's Price-to-Graham-Number is ranked lower than
94% of the 139 Companies
in the Global Medical Devices industry.

( Industry Median: 2.06 vs. WILYY: 10.61 )
Ranked among companies with meaningful Price-to-Graham-Number only.
WILYY' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 3.61  Med: 4.77 Max: 11.4
Current: 10.61
3.61
11.4
Earnings Yield (Greenblatt) % 4.40
WILYY's Earnings Yield (Greenblatt) % is ranked higher than
75% of the 337 Companies
in the Global Medical Devices industry.

( Industry Median: -0.30 vs. WILYY: 4.40 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
WILYY' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 3.5  Med: 5.2 Max: 10.1
Current: 4.4
3.5
10.1
Forward Rate of Return (Yacktman) % 11.97
WILYY's Forward Rate of Return (Yacktman) % is ranked higher than
59% of the 123 Companies
in the Global Medical Devices industry.

( Industry Median: 8.88 vs. WILYY: 11.97 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
WILYY' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 4.6  Med: 12.4 Max: 27.8
Current: 11.97
4.6
27.8

More Statistics

Revenue (TTM) (Mil) $1,698
EPS (TTM) $ 0.39
Beta0.53
Short Percentage of Float0.00%
52-Week Range $8.03 - 11.15
Shares Outstanding (Mil)534.65

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 1,681 1,782 1,904
EPS ($) 0.42 0.48 0.53
EPS without NRI ($) 0.42 0.48 0.53
EPS Growth Rate
(Future 3Y To 5Y Estimate)
11.18%
Dividends per Share ($)

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)